Drug Delivery and Translational Research

Papers
(The H4-Index of Drug Delivery and Translational Research is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Intranasal drug delivery: opportunities and toxicologic challenges during drug development202
Enhancement strategies for transdermal drug delivery systems: current trends and applications159
Nanotechnology-based antiviral therapeutics155
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives105
Current hurdles to the translation of nanomedicines from bench to the clinic96
Current approaches in lipid-based nanocarriers for oral drug delivery85
Ultrasound-responsive polymer-based drug delivery systems76
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine71
Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems62
Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system60
Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress59
Exosomal targeting and its potential clinical application59
Emerging era of “somes”: polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy58
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies49
Clinical translation of gold nanoparticles48
An overview of chitosan and its application in infectious diseases47
Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties47
PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery46
Formulation and evaluation of cubosomes containing colchicine for transdermal delivery46
Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing45
Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems44
Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity43
Development of vaccine formulations: past, present, and future43
Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition42
Recent advances in porous microneedles: materials, fabrication, and transdermal applications40
Enhancement of skin permeability with thermal ablation techniques: concept to commercial products40
Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus38
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects38
Intranasal drug delivery for treatment of Alzheimer’s disease37
QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach36
Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems35
Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections35
Topical delivery of 5-fluorouracil-loaded carboxymethyl chitosan nanoparticles using microneedles for keloid treatment34
In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis34
Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of ma34
Levofloxacin nanoemulsion gel has a powerful healing effect on infected wound in streptozotocin-induced diabetic rats34
0.035833835601807